A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model

OBJECTIVE The prognosis of cancer patients treated with intensity-modulated radiation-therapy (IMRT) is inherently uncertain, depends on many decision variables, and requires that a physician balance competing objectives: maximum tumor control with minimal treatment complications. METHODS In order to better deal with the complex and multiple objective nature of the problem we have combined a prognostic probabilistic model with multi-attribute decision theory which incorporates patient preferences for outcomes. RESULTS The response to IMRT for prostate cancer was modeled. A Bayesian network was used for prognosis for each treatment plan. Prognoses included predicting local tumor control, regional spread, distant metastases, and normal tissue complications resulting from treatment. A Markov model was constructed and used to calculate a quality-adjusted life-expectancy which aids in the multi-attribute decision process. CONCLUSIONS Our method makes explicit the tradeoffs patients face between quality and quantity of life. This approach has advantages over current approaches because with our approach risks of health outcomes and patient preferences determine treatment decisions.

[1]  Alan W Partin,et al.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. , 2007, Urology.

[2]  Anthony V D'Amico,et al.  Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer , 2007, Cancer.

[3]  William Speier,et al.  Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Muren,et al.  Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. , 2008, International journal of radiation oncology, biology, physics.

[5]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[6]  J. Lyman Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.

[7]  E. Venkatraman,et al.  Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A B Wolbarst,et al.  Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.

[9]  Di Yan,et al.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. , 2007, International journal of radiation oncology, biology, physics.

[10]  Susan T. Stewart,et al.  Utilities For Prostate Cancer Health States in Men Aged 60 and Older , 2005, Medical care.

[11]  Susan T Stewart,et al.  Treatment options for localized prostate cancer: quality-adjusted life years and the effects of lead-time. , 2004, Urology.

[12]  Finn V. Jensen,et al.  Bayesian Networks and Decision Graphs , 2001, Statistics for Engineering and Information Science.

[13]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[14]  F. Hamdy,et al.  A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis , 2008, BJU international.

[15]  Joos V Lebesque,et al.  Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.

[16]  Jian Z. Wang,et al.  Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. , 2002, Medical physics.

[17]  Charles R. Thomas,et al.  Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. , 2006, International journal of radiation oncology, biology, physics.

[18]  Leyuan Shi,et al.  A multiplan treatment-planning framework: a paradigm shift for intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[19]  K. Burnham,et al.  Optimization of beam orientation in radiotherapy using planar geometry. , 1998, Physics in medicine and biology.

[20]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  Franca Foppiano,et al.  Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. , 2003, International journal of radiation oncology, biology, physics.

[22]  T. Lawrence,et al.  Ouabain sensitizes tumor cells but not normal cells to radiation. , 1987, International journal of radiation oncology, biology, physics.

[23]  The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma , 2001, Cancer.

[24]  José Mira Mira,et al.  NasoNet, modeling the spread of nasopharyngeal cancer with networks of probabilistic events in discrete time , 2002, Artif. Intell. Medicine.

[25]  J. Beck,et al.  Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[26]  David J. Spiegelhalter,et al.  Probabilistic Networks and Expert Systems , 1999, Information Science and Statistics.

[27]  A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[28]  Jürgen Meyer,et al.  Application of influence diagrams to prostate intensity-modulated radiation therapy plan selection , 2004, Physics in medicine and biology.

[29]  Evert de Jonge,et al.  Prognostic Bayesian networks: I: Rationale, learning procedure, and clinical use , 2007, J. Biomed. Informatics.

[30]  John B. Wong,et al.  The Influence of Influence Diagrams in Medicine , 2005, Decis. Anal..

[31]  P. Lucas,et al.  Computer-based Decision Support in the Management of Primary Gastric non-Hodgkin Lymphoma , 1998, Methods of Information in Medicine.

[32]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  D. Grignon,et al.  Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Weinstein,et al.  Decision Making in Health and Medicine , 2001 .

[35]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[36]  D. Hussey American Society for Therapeutic Radiology and Oncology , 2001 .

[37]  P. Walsh,et al.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. , 1993, The Journal of urology.

[38]  F Foppiano,et al.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  L. Marks,et al.  A dose‐volume‐based tool for evaluating and ranking IMRT treatment plans , 2004, Journal of applied clinical medical physics.

[40]  M G Kahn,et al.  Objective evaluation of 3-D radiation treatment plans: a decision-analytic tool incorporating treatment preferences of radiation oncologists. , 1993, International journal of radiation oncology, biology, physics.

[41]  A. Hanlon,et al.  Defining the optimal radiation dose with three‐dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques , 2001, Cancer.

[42]  Peter J. F. Lucas,et al.  Bayesian networks in biomedicine and health-care , 2004, Artif. Intell. Medicine.